Infectious Diseases (except HIV/AIDS)

  1. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome

    1. Marisol Perez‐Toledo
    2. Sian E. Faustini
    3. Sian E. Jossi
    4. Adrian M. Shields
    5. Edith Marcial‐Juarez
    6. Hari Krishnan Kanthimathinathan
    7. Joel D. Allen
    8. Yasunori Watanabe
    9. Margaret Goodall
    10. Benjamin E. Willcox
    11. Carrie R. Willcox
    12. Mahboob Salim
    13. David C. Wraith
    14. Tonny V. Veenith
    15. Eleni Syrimi
    16. Mark T. Drayson
    17. Deepthi Jyothish
    18. Eslam Al‐Abadi
    19. Ashish Chikermane
    20. Steven B. Welch
    21. Kavitha Masilamani
    22. Scott Hackett
    23. Max Crispin
    24. Barnaby R. Scholefield
    25. Adam F. Cunningham
    26. Alex G. Richter

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR

    1. Tania Desmet
    2. Peter De Paepe
    3. Jerina Boelens
    4. Liselotte Coorevits
    5. Elizaveta Padalko
    6. Stien Vandendriessche
    7. Isabel Leroux-Roels
    8. Annelies Aerssens
    9. Steven Callens
    10. Eva Van Braeckel
    11. Thomas Malfait
    12. Frank Vermassen
    13. Bruno Verhasselt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. CLINICAL PROPERTIES AND DIAGNOSTIC METHODS OF COVID-19 INFECTION IN PREGNANCIES: META-ANALYSIS

    1. Banu Uygun-Can
    2. Bilge Acar-Bolat

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A systematic review of convalescent plasma treatment for COVID19

    1. Ville N. Pimenoff
    2. Miriam Elfström
    3. Joakim Dillner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements

    1. Matthew Quaife
    2. Kevin van Zandvoort
    3. Amy Gimma
    4. Kashvi Shah
    5. Nicky McCreesh
    6. Kiesha Prem
    7. Edwine Barasa
    8. Daniel Mwanga
    9. Beth Kangwana
    10. Jessie Pinchoff
    11. CMMID COVID-19 Working Group
    12. Nikos I. Bosse
    13. Graham Medley
    14. Kathleen O’Reilly
    15. Quentin J. Leclerc
    16. Mark Jit
    17. Rachel Lowe
    18. Nicholas G. Davies
    19. Arminder K. Deol
    20. Gwenan M. Knight
    21. Megan Auzenbergs
    22. W. John Edmunds
    23. Katherine E. Atkins
    24. Thibaut Jombart
    25. Rosalind M. Eggo
    26. Anna M. Foss
    27. Stefan Flasche
    28. Carl A. B. Pearson
    29. Emily S. Nightingale
    30. James D. Munday
    31. Sam Abbott
    32. Billy J. Quilty
    33. Hamish P. Gibbs
    34. David Simons
    35. Jon C. Emery
    36. Stéphane Hué
    37. Yang Liu
    38. Damien C. Tully
    39. Alicia Rosello
    40. Simon R. Procter
    41. Akira Endo
    42. Timothy W. Russell
    43. Eleanor M. Rees
    44. Charlie Diamond
    45. Sophie R. Meakin
    46. Adam J. Kucharski
    47. Georgia R. Gore-Langton
    48. Petra Klepac
    49. Joel Hellewell
    50. Fiona Yueqian Sun
    51. Rein M. G. J. Houben
    52. C. Julian Villabona-Arenas
    53. Sebastian Funk
    54. Samuel Clifford
    55. Oliver Brady
    56. W. John Edmunds
    57. Christopher I. Jarvis
    58. Karen Austrian

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A shred of evidence that BCG vaccine may protect against COVID-19: Comparing cohorts in Spain and Italy

    1. David I. Levine

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. The effect of strict lock down measures on Covid-19 seroprevalence rate and herd immunity

    1. Maher A. Sughayer
    2. Asem Mansour
    3. Abeer Al Nuirat
    4. Lina Souan
    5. Mohammad Ghanem
    6. Mahmoud Siag

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

    1. Nathaniel J Rhodes
    2. Atheer Dairem
    3. William J Moore
    4. Anooj Shah
    5. Michael J Postelnick
    6. Melissa E Badowski
    7. Sarah M Michienzi
    8. Jaime L Borkowski
    9. Radhika S Polisetty
    10. Karen Fong
    11. Emily S Spivak
    12. James R Beardsley
    13. Cory M Hale
    14. Andrea M Pallotta
    15. Pavithra Srinivas
    16. Lucas T Schulz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19

    1. Wen-Na Xi
    2. Di Jin
    3. Ke Sun
    4. Rong-Yan Yu
    5. Xue-Bing Yao
    6. Biao-Shu Zou
    7. Zhi-Ying Song
    8. AO-Yu Yang
    9. Rui-Xia Luo
    10. Yun liu
    11. Yan-hua Li
    12. Shui-Lin Sun
    13. Dong-Shan Yu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity

    1. Thomas Perkmann
    2. Nicole Perkmann-Nagele
    3. Marie-Kathrin Breyer
    4. Robab Breyer-Kohansal
    5. Otto C Burghuber
    6. Sylvia Hartl
    7. Daniel Aletaha
    8. Daniela Sieghart
    9. Peter Quehenberger
    10. Rodrig Marculescu
    11. Patrick Mucher
    12. Robert Strassl
    13. Oswald F Wagner
    14. Christoph J Binder
    15. Helmuth Haslacher

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 48 of 716 Next